Cargando…
Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
Neurokinins (or tachykinins) are peptides that modulate a wide variety of human physiology through the neurokinin G protein-coupled receptor family, implicated in a diverse array of pathological processes. Here we report high-resolution crystal structures of the human NK(1) receptor (NK(1)R) bound t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318301/ https://www.ncbi.nlm.nih.gov/pubmed/30604743 http://dx.doi.org/10.1038/s41467-018-07939-8 |
_version_ | 1783384848026566656 |
---|---|
author | Schöppe, Jendrik Ehrenmann, Janosch Klenk, Christoph Rucktooa, Prakash Schütz, Marco Doré, Andrew S. Plückthun, Andreas |
author_facet | Schöppe, Jendrik Ehrenmann, Janosch Klenk, Christoph Rucktooa, Prakash Schütz, Marco Doré, Andrew S. Plückthun, Andreas |
author_sort | Schöppe, Jendrik |
collection | PubMed |
description | Neurokinins (or tachykinins) are peptides that modulate a wide variety of human physiology through the neurokinin G protein-coupled receptor family, implicated in a diverse array of pathological processes. Here we report high-resolution crystal structures of the human NK(1) receptor (NK(1)R) bound to two small-molecule antagonist therapeutics – aprepitant and netupitant and the progenitor antagonist CP-99,994. The structures reveal the detailed interactions between clinically approved antagonists and NK(1)R, which induce a distinct receptor conformation resulting in an interhelical hydrogen-bond network that cross-links the extracellular ends of helices V and VI. Furthermore, the high-resolution details of NK(1)R bound to netupitant establish a structural rationale for the lack of basal activity in NK(1)R. Taken together, these co-structures provide a comprehensive structural basis of NK(1)R antagonism and will facilitate the design of new therapeutics targeting the neurokinin receptor family. |
format | Online Article Text |
id | pubmed-6318301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63183012019-01-07 Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists Schöppe, Jendrik Ehrenmann, Janosch Klenk, Christoph Rucktooa, Prakash Schütz, Marco Doré, Andrew S. Plückthun, Andreas Nat Commun Article Neurokinins (or tachykinins) are peptides that modulate a wide variety of human physiology through the neurokinin G protein-coupled receptor family, implicated in a diverse array of pathological processes. Here we report high-resolution crystal structures of the human NK(1) receptor (NK(1)R) bound to two small-molecule antagonist therapeutics – aprepitant and netupitant and the progenitor antagonist CP-99,994. The structures reveal the detailed interactions between clinically approved antagonists and NK(1)R, which induce a distinct receptor conformation resulting in an interhelical hydrogen-bond network that cross-links the extracellular ends of helices V and VI. Furthermore, the high-resolution details of NK(1)R bound to netupitant establish a structural rationale for the lack of basal activity in NK(1)R. Taken together, these co-structures provide a comprehensive structural basis of NK(1)R antagonism and will facilitate the design of new therapeutics targeting the neurokinin receptor family. Nature Publishing Group UK 2019-01-03 /pmc/articles/PMC6318301/ /pubmed/30604743 http://dx.doi.org/10.1038/s41467-018-07939-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Schöppe, Jendrik Ehrenmann, Janosch Klenk, Christoph Rucktooa, Prakash Schütz, Marco Doré, Andrew S. Plückthun, Andreas Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
title | Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
title_full | Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
title_fullStr | Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
title_full_unstemmed | Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
title_short | Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
title_sort | crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318301/ https://www.ncbi.nlm.nih.gov/pubmed/30604743 http://dx.doi.org/10.1038/s41467-018-07939-8 |
work_keys_str_mv | AT schoppejendrik crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists AT ehrenmannjanosch crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists AT klenkchristoph crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists AT rucktooaprakash crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists AT schutzmarco crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists AT doreandrews crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists AT pluckthunandreas crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists |